Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Seizures 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8Radiotherapy 7Temozolomide 5Carboplatin 5Vincristine 4etoposide phosphate 3Methotrexate 3Etoposide 3Busulfan 3Biopsy 3Thiotepa 2Surveys and Questionnaires 2Melphalan 2Magnetic Resonance Imaging 2Lomustine 2Cisplatin 2Chemotherapy, Adjuvant 2alovudine 1Yoga 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Rituximab 1Remote Consultation 1Radiation 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Oxycodone 1Ocoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Central Nervous System Neoplasms × Levetiracetam × Clear all
NCT00415376 2012-05-18

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Northwestern University

Phase NA Withdrawn
CNS

Brain Neoplasms, Seizures, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡